Literature DB >> 19446489

Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.

Esen Saka1, Bülent Elibol.   

Abstract

Cognitive impairment either as dementia (PD-D) or mild cognitive impairment (PD-MCI) is common in Parkinson's disease (PD). The clinical features and cognitive profile differs from Alzheimer's disease (AD) or amnestic MCI (aMCI). In this study we aim to disclose the utility of pre-selected practical neuropsychological tests in differentiation of PD-D and AD, and also PD-MCI and aMCI. Consecutive cases with mild to moderate AD (n = 32) and PD-D (n = 26); aMCI (n = 34) and PD-MCI (n = 19) were evaluated. Although MMSE scores were similar in PD-D and AD or in PD-MCI and aMCI groups, memory impairment assessed by enhanced cued recall (ECR) was more apparent in AD than PD-D; and ECR scores tended to be worse in aMCI group than PD-MCI group. In contrast, clock drawing was more impaired in PD-D than AD. For differentiation of PD-D from AD, ECR, clock drawing and letter fluency were found to be valuable with moderately high sensitivity and specificities. In differentiation of aMCI and PD-MCI, ECR, clock drawing test and copying of intersecting pentagons were helpful. Stepwise linear discrimination function analysis disclosed that combination of ECR and clock drawing tests correctly classified 70.7% of the overall study population (71.4% of AD, 71.9% of aMCI, 69.6% of PD-D and 68.8% of PD-MCI). These findings suggest that ECR and clock drawing tests can be valuable as an additive to clinical diagnostic criteria in differentiation of PD-D and PD-MCI cases from AD and aMCI.

Entities:  

Mesh:

Year:  2009        PMID: 19446489     DOI: 10.1016/j.parkreldis.2009.04.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Authors:  G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz
Journal:  Alzheimers Dement       Date:  2012-11-16       Impact factor: 21.566

Review 2.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

3.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

4.  Cognitive profiles in Mild Cognitive Impairment (MCI) patients associated with Parkinson's disease and cognitive disorders.

Authors:  Michele Pistacchi; Manuela Gioulis; Franco Contin; Flavio Sanson; Sandro Zambito Marsala
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

5.  eCorsi: implementation and testing of the Corsi block-tapping task for digital tablets.

Authors:  Riccardo Brunetti; Claudia Del Gatto; Franco Delogu
Journal:  Front Psychol       Date:  2014-09-02

6.  Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination.

Authors:  Krisly Arguedas Vásquez; Erick Miranda Valverde; Daniel Valerio Aguilar; Henri-Jacques Hernández Gabarain
Journal:  Dement Neuropsychol       Date:  2019 Jan-Mar

7.  Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments.

Authors:  Anja Ophey; Steffen Wolfsgruber; Sandra Roeske; Alexandra Polcher; Annika Spottke; Lutz Frölich; Michael Hüll; Frank Jessen; Johannes Kornhuber; Wolfgang Maier; Oliver Peters; Alfredo Ramirez; Jens Wiltfang; Inga Liepelt-Scarfone; Sara Becker; Daniela Berg; Jörg B Schulz; Kathrin Reetz; Jennifer Wojtala; Jan Kassubek; Alexander Storch; Monika Balzer-Geldsetzer; Rüdiger Hilker-Roggendorf; Karsten Witt; Brit Mollenhauer; Claudia Trenkwalder; Hans-Ullrich Wittchen; Oliver Riedel; Richard Dodel; Michael Wagner; Elke Kalbe
Journal:  Alzheimers Dement (Amst)       Date:  2021-09-14

8.  Cognitive profiles of patients with mild cognitive impairment or dementia in Alzheimer's or Parkinson's disease.

Authors:  Helmut Hildebrandt; Frauke Fink; Andreas Kastrup; Michael Haupts; Paul Eling
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-04-03

9.  Free and cued recall memory in Parkinson's disease associated with amnestic mild cognitive impairment.

Authors:  Alberto Costa; Marco Monaco; Silvia Zabberoni; Antonella Peppe; Roberta Perri; Lucia Fadda; Francesca Iannarelli; Carlo Caltagirone; Giovanni A Carlesimo
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Cognitive Dysfunction in Relation to Topography and Burden of Cerebral Microbleeds.

Authors:  Gülseren Büyükşerbetçi; Esen Saka; Kader Karli Oğuz; Rahşan Göçmen; Ethem Murat Arsava; Mehmet Akif Topçuoğlu
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.